,
Beverley Moore and
Adrian Howard 
Other Industry News
Health Canada has published a Guidance Document Questions and Answers: Plain Language Labelling Regulations.
Health Canada has announced the Adoption of ICH Guidance Document: Q4B Annex 6: Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Uniformity of Dosage Units General Chapter.
Health Canada has announced the Adoption of International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Guidance: Q4B Annex 11: Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regionson Capillary Electrophoresis General Chapter.
Health Canada has announced the Adoption of International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Guidance Document: Q4B Annex 13: Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Bulk Density and Tapped Density of Powders General Chapter.
Health Canada has announced the Adoption of International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Guidance Document: Q4B Annex 14: Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Bacterial Endotoxins Test General Chapter.
The Natural and Non-prescription Health Products Directorate has announced a Consultation – New Labelling Standard (Oral Adult Decongestant).
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
